Sandoz US to divest dermatology and oral solids businesses to Aurobindo Pharma for $1bn

In a strategic move within the pharmaceutical industry, Sandoz US, a subsidiary of the Swiss-based Novartis, has announced the sale of its dermatology and oral ... Read More